Topic: Tumor Microenvironment and Cancer Metastasis
A Special Issue of Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)
Submission deadline: 27 Dec 2024
Guest Editor(s)
Special Issue Introduction
The tumor microenvironment (TME) is a complex and dynamic ecosystem surrounding cancer cells, consisting of diverse cellular and non-cellular components. Cellular elements include cancer-associated fibroblasts (CAFs), immune cells, endothelial cells, etc. Non-cellular components encompass soluble factors like growth factors and cytokines, extracellular matrix (ECM), and physical properties such as hypoxia.
The intricate network of interactions between tumor cells and the TME plays a pivotal role in tumor progression and metastasis. The TME influences each stage of the metastatic cascade through various mechanisms. For instance, CAFs can promote tumor invasion and metastasis by remodeling the ECM and secreting growth factors that stimulate cancer cell proliferation and migration. Immune cells within the TME can exhibit both anti- and pro-tumor functions. Additionally, the abnormal hypoxic conditions and tumor vasculature in the TME can facilitate cancer cell intravasation and dissemination.
Understanding the intricate interplay between tumor cells and the TME is essential for unraveling the mechanisms driving cancer metastasis and for developing effective therapeutic strategies. Targeting components of the TME that promote metastasis holds promise for preventing or inhibiting the spread of cancer and improving patient outcomes.
Potential topics of interest include but are not limited to:
'1. Comparative analysis of TME characteristics across diverse cancer types;
2. Unveiling signaling pathways orchestrating TME-mediated immune evasion or cancer cell invasion;
3. Exploring the association between TME dynamics and cancer stem cells during cancer progression;
4. Enhancing immunotherapeutic efficacy in metastatic or late-stage cancer: Innovative strategies unveiled;
5. Revealing the molecular mechanisms governing TME-tumorigenesis crosstalk;
6. Novel therapeutic paradigms: Interfering with TME-cancer cell interactions;
7. Understanding cancer drug resistance and potential factors contributing to cancer metastasis within the TME;
8. Investigating ECM remodeling and its role in cancer metastasis: Unraveling the dynamics;
9. Utilizing omics research or analysis to dissect the role of TME during cancer progression and metastasis.
The intricate network of interactions between tumor cells and the TME plays a pivotal role in tumor progression and metastasis. The TME influences each stage of the metastatic cascade through various mechanisms. For instance, CAFs can promote tumor invasion and metastasis by remodeling the ECM and secreting growth factors that stimulate cancer cell proliferation and migration. Immune cells within the TME can exhibit both anti- and pro-tumor functions. Additionally, the abnormal hypoxic conditions and tumor vasculature in the TME can facilitate cancer cell intravasation and dissemination.
Understanding the intricate interplay between tumor cells and the TME is essential for unraveling the mechanisms driving cancer metastasis and for developing effective therapeutic strategies. Targeting components of the TME that promote metastasis holds promise for preventing or inhibiting the spread of cancer and improving patient outcomes.
Potential topics of interest include but are not limited to:
'1. Comparative analysis of TME characteristics across diverse cancer types;
2. Unveiling signaling pathways orchestrating TME-mediated immune evasion or cancer cell invasion;
3. Exploring the association between TME dynamics and cancer stem cells during cancer progression;
4. Enhancing immunotherapeutic efficacy in metastatic or late-stage cancer: Innovative strategies unveiled;
5. Revealing the molecular mechanisms governing TME-tumorigenesis crosstalk;
6. Novel therapeutic paradigms: Interfering with TME-cancer cell interactions;
7. Understanding cancer drug resistance and potential factors contributing to cancer metastasis within the TME;
8. Investigating ECM remodeling and its role in cancer metastasis: Unraveling the dynamics;
9. Utilizing omics research or analysis to dissect the role of TME during cancer progression and metastasis.
Submission Deadline
27 Dec 2024
Submission Information
For Author Instructions, please refer to https://www.oaepublish.com/jcmt/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=jcmt&SpecialIssueId=jcmt20240329
Submission Deadline: 27 Dec 2024
Contacts: Wendy Liu, Assistant Editor, wendy@oaeservice.com
